Dominique Schols Selected Research

Viral Antigens

1/2016	The Viral Polymerase Inhibitor 7-Deaza-2'-C-Methyladenosine Is a Potent Inhibitor of In Vitro Zika Virus Replication and Delays Disease Progression in a Robust Mouse Infection Model.
11/2004	CADA, a novel CD4-targeted HIV inhibitor, is synergistic with various anti-HIV drugs in vitro.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dominique Schols Research Topics

Disease

60	Infections 01/2024 - 04/2002
28	Neoplasms (Cancer) 03/2024 - 11/2002
18	HIV Infections (HIV Infection) 01/2024 - 01/2003
13	Acquired Immunodeficiency Syndrome (AIDS) 03/2024 - 01/2003
9	Carcinoma (Carcinomatosis) 10/2022 - 07/2014
6	Neoplasm Metastasis (Metastasis) 03/2024 - 10/2004
6	Human Influenza (Influenza) 11/2022 - 07/2014
6	Inflammation (Inflammations) 05/2022 - 04/2002
5	Leukemia 03/2024 - 01/2016
5	COVID-19 01/2023 - 11/2020
4	Virus Diseases (Viral Diseases) 01/2023 - 08/2008
4	Reperfusion Injury 12/2022 - 11/2016
4	Primary Graft Dysfunction 12/2022 - 01/2017
4	Dengue (Dengue Fever) 10/2021 - 12/2010
4	Leukemia L1210 01/2020 - 07/2014
3	Ovarian Neoplasms (Ovarian Cancer) 03/2022 - 11/2021
3	Zika Virus Infection 10/2021 - 01/2020
3	Yellow Fever 01/2021 - 01/2018
2	Multiple Myeloma 03/2024 - 01/2019
2	Coinfection 11/2022 - 01/2020
2	Adenocarcinoma 10/2022 - 11/2019
2	Lymphoma (Lymphomas) 01/2021 - 10/2014
2	Severe Acute Respiratory Syndrome 01/2021 - 01/2021
2	Breast Neoplasms (Breast Cancer) 01/2021 - 12/2019
2	Autoimmune Diseases (Autoimmune Disease) 01/2021 - 01/2020
2	Asthma (Bronchial Asthma) 11/2015 - 04/2002
2	Rheumatoid Arthritis 11/2015 - 10/2004
2	Vesicular Stomatitis 07/2014 - 05/2002
1	Tropical Spastic Paraparesis (Tropical Spastic Paraplegia) 12/2022
1	Neuroinflammatory Diseases 12/2022
1	Necrosis 12/2022
1	Viral Pneumonia 11/2022

Drug/Important Bio-Agent (IBA)

31	Antiviral Agents (Antivirals)IBA 01/2023 - 10/2002
17	Chemokine ReceptorsIBA 03/2024 - 01/2003
13	plerixafor FDA Link 03/2024 - 04/2002
8	DC-specific ICAM-3 grabbing nonintegrin (DC-SIGN)IBA 01/2015 - 08/2008
7	LigandsIBA 05/2022 - 01/2003
7	Anti-Infective Agents (Microbicides)IBA 05/2021 - 10/2004
7	Cytostatic AgentsIBA 01/2020 - 07/2014
6	CytokinesIBA 12/2022 - 11/2002
6	ChemokinesIBA 11/2022 - 06/2003
6	DNA (Deoxyribonucleic Acid)IBA 08/2022 - 07/2014
5	Proteins (Proteins, Gene)FDA Link 11/2021 - 04/2002
5	CarbohydratesIBA 01/2021 - 01/2007
4	AcidsIBA 10/2022 - 01/2017
4	VaccinesIBA 01/2021 - 01/2012
4	LectinsIBA 12/2016 - 08/2010
4	Mannose (D-Mannose)IBA 08/2010 - 10/2004
3	CXC ChemokinesIBA 03/2024 - 10/2018
3	CXCR4 Receptors (CXCR4 Receptor)IBA 01/2024 - 10/2004
3	Monoclonal AntibodiesIBA 01/2023 - 04/2002
3	InterferonsIBA 01/2023 - 11/2020
3	Anti-Bacterial Agents (Antibiotics)IBA 11/2022 - 12/2010
3	Prostaglandins DIBA 02/2021 - 01/2017
3	ThiadiazolesIBA 02/2021 - 09/2014
3	NucleosidesIBA 09/2018 - 01/2015
3	Polysaccharides (Glycans)IBA 12/2016 - 08/2010
3	Maraviroc FDA Link 10/2014 - 04/2011
3	Plant LectinsIBA 05/2005 - 10/2004
2	1,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA 03/2024 - 10/2021
2	68Ga-pentixaforIBA 03/2024 - 10/2021
2	CCR8 ReceptorsIBA 01/2024 - 01/2021
2	Heparitin Sulfate (Heparan Sulfate)IBA 12/2022 - 01/2013
2	Peptides (Polypeptides)IBA 12/2022 - 01/2010
2	Interleukin-17 (Interleukin 17)IBA 11/2022 - 09/2015
2	quinolineIBA 10/2022 - 01/2021
2	Chloroquine (Aralen)FDA LinkGeneric 10/2022 - 09/2008
2	AntibodiesIBA 08/2022 - 01/2005
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 05/2022 - 11/2002
2	AllergensIBA 01/2022 - 04/2002
2	Biomarkers (Surrogate Marker)IBA 11/2021 - 04/2016
2	AntigensIBA 01/2021 - 01/2005
2	Glycoproteins (Glycoprotein)IBA 01/2020 - 12/2012
2	Organophosphonates (Phosphonates)IBA 01/2019 - 01/2018
2	ProdrugsIBA 01/2018 - 01/2017
2	Thymidine KinaseIBA 09/2017 - 05/2002
2	Oleanolic AcidIBA 01/2017 - 01/2016
2	Carrier Proteins (Binding Protein)IBA 12/2016 - 11/2005
2	Viral AntigensIBA 01/2016 - 11/2004
2	Tenofovir (Viread)FDA Link 01/2012 - 06/2011
2	Drug CombinationsIBA 09/2011 - 01/2004
2	CD4 Antigens (CD4 Antigen)IBA 01/2006 - 08/2005
2	Indicators and Reagents (Reagents)IBA 06/2003 - 01/2003
1	Conditioned Culture MediaIBA 01/2024
1	Interleukin-2 (IL2)IBA 01/2024
1	Macrocyclic CompoundsIBA 01/2024
1	SpermidineIBA 01/2023
1	SpermineIBA 01/2023
1	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2022
1	Tissue Inhibitor of MetalloproteinasesIBA 11/2022
1	Protease Inhibitors (Protease Inhibitor)IBA 11/2022
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 11/2022
1	Chemotactic FactorsIBA 11/2022
1	ElafinIBA 11/2022

Therapy/Procedure

8	Therapeutics 03/2024 - 01/2003
5	Immunotherapy 01/2024 - 01/2021
4	Lung Transplantation 12/2022 - 01/2017
2	Drug Therapy (Chemotherapy) 03/2022 - 01/2006
2	Highly Active Antiretroviral Therapy (HAART) 08/2011 - 01/2004
1	Artificial Respiration (Mechanical Ventilation) 11/2022